| |
 |
Daniel A. Vallera Patents |
|
Inventor: Vallera; Daniel A.
Address: St. Louis Park, MN
No. of patents: 5
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7101542 |
Cell-mediated targeting of toxins to pathogenic cells |
September 5, 2006 |
| The invention features vectors encoding immunotoxic fusion proteins containing targeting domains and toxic domains, targeting cells transduced with the vectors, methods of making the targeting cells, and methods of treating diseases (e.g., cancer) using both the vectors and the trans |
| 6846484 |
DTAT fusion toxin |
January 25, 2005 |
| The invention provides fusion toxins that contain one or more regions of diphtheria toxin and a portion of urokinase-type plasminogen activator, as well as the nucleic acids that encode the fusion toxins and methods of using the fusion toxins. |
| 6492498 |
Multimeric immunotoxins |
December 10, 2002 |
| The invention features fusion protein monomers, multimeric immunotoxic proteins, nucleic acids encoding fusion protein monomers, vectors containing the nucleic acids, and cells containing the vectors. Also encompassed by the invention are methods of killing pathogenic cells and makin |
| 6001329 |
Radiolabeled fusion toxins for cancer therapy |
December 14, 1999 |
| The present invention provides the synthesis and purification of a new class of compounds known as radiolabeled fusion toxins (RFT), in which both toxin and radionuclide tags are contained on the same growth factor, for example, murine granulocyte macrophage colony stimulating factor, |
| 4831122 |
Radioimmunotoxins |
May 16, 1989 |
| Radioimmunotoxins consisting of a monoclonal antibody covalently coupled to a toxin and a radionuclide. The compositions retain high binding specificity and cytotoxic activity and are useful in treating cancer and in bone marrow transplantation. The antibody component determines the |
|
|
|
